Epigenetics: Novel mechanism of pulmonary hypertension

Lung

Volumn 191, Issue 6, 2013, Pages 601-610

  Huang, Jing Bin ^a   Liang, Jian ^a   Zhao, Xiao Fang ^a   Wu, Wen Sen ^a   Zhang, Fu ^a  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

DNA methylation; Histone acetylation; MicroRNAs; Network biology; Pulmonary hypertension

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA; MICRORNA 145; MICRORNA 150; MICRORNA 17; MICRORNA 204; MICRORNA 206; MICRORNA 20A; MICRORNA 21; MICRORNA 210; MICRORNA 328; MICRORNA 424; MICRORNA 503; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENETIC REGULATION; GENOME IMPRINTING; GENOTYPE ENVIRONMENT INTERACTION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PULMONARY HYPERTENSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; GENOMICS; HISTONES; HUMANS; HYPERTENSION, PULMONARY; MICRORNAS; PHENOTYPE; PROGNOSIS; SYSTEMS BIOLOGY;

EID: 84890329231     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9505-1     Document Type: Article

References (93)

1. Sten YC, Jose L et al (2008) Pathogenic mechanisms of pulmonary hypertension. J Mol Cell Cardiol 44:14-30
2. Huang JB, Liu YL, Yu CT et al (2011) Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease. Int J Cardiol 151:76-83
3. Huang JB, Liu YL, Sun PW et al (2010) Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis. Lung 188:179-189
4. Huang JB, Liang J, Zhou LY et al (2012) Eisenmenger syndrome: not always inoperable. Respir Care 57:1488-1495
5. Kim GH, Ryan JJ, Marsboom G et al (2011) Epigenetic mechanisms of pulmonary hypertension. Pulm Circ 1:347-356
6. Barabasi AL, Gulbahce N, Loscalzo J et al (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56-68
7. Cho D-Y, Kim Y-A, Przytycka TM (2012) Chapter 5: Network biology approach to complex diseases. PLoS Comput Biol 18:e1002820
8. Allis CD, Jenuwein T, Reinberg D (2009) Epigenetics. Cold Spring Harbor Laboratory Press, Woodbury
9. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196:261-282
10. Espada J, Esteller M (2010) DNA methylation and the functional organization of the nuclear compartment. Semin Cell Dev Biol 21:238-246
11. Randhawa R, Cohen P (2005) The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86:84-90
12. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447:433-440
13. Doi A, Park IH, Wen B et al (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350-1353
14. Ji H, Ehrlich LI, Seita J et al (2001) Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467:338-342
15. Jones PA, Takai D et al (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070
16. Maunakea AK, Nagarajan RP, Bilenky M et al (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466:253-257
17. Lister R, Pelizzola M, Dowen RH et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315-322
18. Branco MR, Ficz G, Reik W (2012) Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13:7-13
19. Szulwach KE, Li X, Li Y et al (2011) Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet 7:e1002154
20. Chi P, Allis CD, Wang GG (2010) Covalent histone modifications - miswritten, misinterpret and mis-erased in human cancers. Nat Rev Cancer 10:457-469
21. de Ruijter AJ, van Gennip AH, Caron HN et al (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737-749
22. Tamaru H, Selker EU (2001) A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414:277-283
23. Flynt AS, Lai EC (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 9:831-842
24. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714
25. Papageorgiou N, Tousoulis D, Androulakis E et al (2012) The role of microRNAs in cardiovascular disease. Curr Med Chem 19:2605-2610
26. Jopling C (2012) Liver-specific microRNA-122: biogenesis and function. RNA Biol 9:137-142
27. Reik W, Walter J (2001) Genomic imprinting: parental influence on the genome. Nat Rev Genet 2:21-32
28. Archer SL, Weir EK, Wilkins MR (2010) Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121:2045-2066
29. Hagen M, Fagan K, Steudel W et al (2007) Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol 292:L1473-L1479
30. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
31. Wu N, Sulpice E, Obeid P et al (2012) The miR-17 family links p63 protein to MAPK signaling to promote the onset of human keratinocyte differentiation. PLoS ONE 7:e45761
32. Kjaer-Frifeldt S, Hansen TF, Nielsen BS et al (2012) The prognostic importance of miR-21 in stage II colon cancer: a population-based study. Br J Cancer 107:1169-1174
33. Yokobori T, Suzuki S, Tanaka N et al (2013) MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci 104:48-54
34. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767-801
35. Cai X (2006) Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies. Expert Rev Cardiovasc Ther 4:789-800
36. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355
37. Chen K, Rajewsky N (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8:93-103
38. Morrell NW, Yang X, Upton PD et al (2001) Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 104:790-795
39. Takemoto M, Sun J, Hiroki J et al (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106:57-62
40. Li X, Zhang X, Leathers R et al (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15:1289-1297
41. Joshi SR, McLendon JM, Comer BS et al (2011) MicroRNAs-control of essential genes: implications for pulmonary vascular disease. Pulm Circ 1:357-364
42. Bockmeyer CL, Maegel L, Janciauskiene S et al (2012) Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant 31:764-772
43. Pullamsetti SS, Doebele C, Fischer A et al (2012) Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 185:409-419
44. Yang S, Banerjee S, Freitas AD et al (2012) miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 302:L521-L529
45. Parikh VN, Jin RC, Rabello S et al (2012) MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125:1520-1532
46. Caruso P, Dempsie Y, Stevens HC et al (2012) A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res 111:290-300
47. Rhodes CJ, Wharton J, Boon RA et al (2013) Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 187:294-302
48. Courboulin A, Paulin R, Giguère NJ et al (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208:535-548
49. Jalali S, Ramanathan GK, Parthasarathy PT et al (2012) Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. PLoS ONE 7:e46808
50. Gou D, Ramchandran R, Peng X et al (2012) miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am J Physiol Lung Cell Mol Physiol 303:L682-L691
51. Guo L, Qiu Z, Wei L et al (2012) The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C. Hypertension 59:1006-1013
52. Kim J, Kang Y, Kojima Y et al (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19:74-82
53. Fish JE, Santoro MM, Morton SU et al (2008) Mir-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15:272-284
54. van Solingen C, Seghers L, Bijkerk R et al (2009) Antagomir-mediated silencing of endothelial cell specific microrna-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13:1577-1585
55. Cracowski JL, Leuchte HH (2012) The potential of biomarkers in pulmonary arterial hypertension. Am J Cardiol 110:32S-38S
56. Caruso P, MacLean MR, Khanin R et al (2010) Dynamic changes in lung microrna profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30:716-723
57. Pickering MT, Stadler BM, Kowalik TF (2009) Mir-17 and mir-20a temper an e2f1-induced g1 checkpoint to regulate cell cycle progression. Oncogene 28:140-145
58. Fontana L, Fiori ME, Albini S et al (2008) Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and bim. PLoS ONE 3:e2236
59. Taguchi A, Yanagisawa K, Tanaka M et al (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for mir-17-92 microrna cluster. Cancer Res 68:5540-5545
60. Petrocca F, Vecchione A, Croce CM (2008) Emerging role of mir-106b-25/mir-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68:8191-8194
61. Brock M, Trenkmann M, Gay RE et al (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel stat3-microrna cluster 17/92 pathway. Circ Res 104:1184-1191
62. Tagawa H, Karube K, Tsuzuki S et al (2007) Synergistic action of the microrna-17 polycistron and myc in aggressive cancer development. Cancer Sci 98:1482-1490
63. Volinia S, Calin GA, Liu CG et al (2006) A microrna expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261
64. Wong WK, Knowles JA, Morse JH (2005) Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 33:438-446
65. Brock M, Trenkmann M, Gay RE et al (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 104:1184-1191
66. Bonnet S, Rochefort G, Sutendra G et al (2007) The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA 104:11418-11423
67. Zhao L, al-Tubuly R, Sebkhi A et al (1996) Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol 119:1217-1222
68. Archer S, Rich S (2000) Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". Circulation 102:2781-2791
69. Yellaturu CR, Rao GN (2003) Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BB-induced growth in vascular smooth muscle cells. J Biol Chem 278:9986-9992
70. Banes-Berceli AK, Ketsawatsomkron P, Ogbi S et al (2007) Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol 293:H1291-H1299
71. Wang FE, Zhang C, Maminishkis A et al (2010) MicroRNA-204/211 alters epithelial physiology. FASEB J 24:1552-1571
72. Rafeq S, Shah AM, Preston IR (2009) Biomarkers in pulmonary arterial hypertension. Int J Clin Pract Suppl 162:36-41
73. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518
74. Fichtlscherer S, De Rosa S, Fox H et al (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677-684
75. Valadi H, Ekstrom K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659
76. Gupta SK, Bang C, Thum T (2010) Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 3:484-488
77. Kosaka N, Iguchi H, Ochiya T (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101:2087-2092
78. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA et al (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107:6328-6333
79. Huang JB, Liang J, Du M (2012) Clinical and pathologic comparison of simple left-to-right shunt congenital heart disease and transposition of the great arteries with ventricular septal defect. Heart Surg Forum 15:E97-E102
80. Caruso P, MacLean MR, Khanin R et al (2010) Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30:716-723
81. Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9:107-183
82. Kulshreshtha R, Ferracin M, Wojcik SE et al (2007) A microRNA signature of hypoxia. Mol Cell Biol 27:1859-1867
83. Ghosh G, Subramanian IV, Adhikari N et al (2010) Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 120:4141-4154
84. Caruso P, MacLean MR, Khanin R et al (2010) Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30:716-723
85. White K, Joseph Loscalzo J, Chan SY (2012) Holding our breath: the emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ 2:278-290
86. Chan SY, White K, Loscalzo J (2012) Deciphering the molecular basis of human cardiovascular disease through network biology. Curr Opin Cardiol 27:202-209
87. Barabasi AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56-68
88. Lusis AJ, Weiss JN (2010) Cardiovascular networks: systems-based approaches to cardiovascular disease. Circulation 121:157-170
89. Jensen MK, Pers TH, Dworzynski P et al (2011) Protein interaction-based genome-wide analysis of incident coronary heart disease. Circ Cardiovasc Genet 4:549-556
90. Cho D-Y, Kim Y-A, Przytycka TM (2012) Chapter 5: network biology approach to complex diseases. PLoS Comput Biol 8:e1002820
91. Loscalzo J, Kohane I, Barabasi AL (2007) Human disease classification in the post-genomic era: a complex systems approach to human pathobiology. Mol Syst Biol 3:124
92. Xu XF, Ma XL, Shen Z et al (2010) Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat. J Hypertens 28:2227-2235
93. Archer SL, Marsboom G, Kim GH et al (2010) Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121:2661-2671